CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 65 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $316 | +1655.6% | 727 | +2592.6% | 0.00% | – |
| Q4 2022 | $18 | – | 27 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 27 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 27 | -78.7% | 0.00% | – |
| Q1 2022 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 127 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 127 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 127 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 127 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $6,156,000 | 0.40% |
| MFN Partners Management, LP | 3,389,215 | $2,915,000 | 0.13% |
| Diametric Capital, LP | 243,711 | $210,000 | 0.11% |
| Artal Group S.A. | 2,779,122 | $2,391,000 | 0.10% |
| Intrinsic Value Partners, LLC | 48,315 | $42,000 | 0.06% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 292,645 | $252,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $99,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 92,541 | $80,000 | 0.00% |
| COLONY GROUP LLC | 102,884 | $88,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 231,952 | $198,000 | 0.00% |